rawfin.tv
Health Catalyst Forecasts $246M-$249M 2026 Revenue Post-Vitalware Divestiture
MarketsstocksAI Generated

Health Catalyst Forecasts $246M-$249M 2026 Revenue Post-Vitalware Divestiture

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Health Catalyst projects 2026 revenue between $246 million and $249 million after divesting Vitalware. The revised outlook reflects strategic adjustments to its business portfolio.

HCATRevenue GuidanceHealthcare Tech

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks